Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery

Archives of Ophthalmology

Volumn 124, Issue 11, 2006, Pages 1558-1565

  Dayani, Pouya N ^a   Grand, M Gilbert ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES RETINA INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CLOPIDOGREL; COUMARIN; ROFECOXIB; WARFARIN;

ADOLESCENT; ADULT; AGED; CILIARY DISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; LUNG EMBOLISM; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; VITRECTOMY; VITREORETINOPATHY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATIONS; PROTHROMBIN TIME; RETINAL DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; VITRECTOMY; VITREOUS HEMORRHAGE; WARFARIN;

EID: 33750991595     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.11.1558     Document Type: Review

References (29)

1. Jafri SM. Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J. 2004;147:3-15.
2. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med. 2003;163:901-908.
3. Poller L, Thomson J. Evidence for "rebound" hypercoagulability after stopping anticoagulants. Lancet. 1964;39:62-64.
4. Palareti G, Legnani C, Guazzaloca G, et al. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants: a prospective study. Thromb Haemost. 1994;72:222-226.
5. Genewein U, Haeberli A, Straub PW, Beer JH. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol. 1996;92:479-485.
6. Rustad H, Myhre E. Surgery during anticoagulant treatment: the risk of increased bleeding in patients on oral anticoagulant treatment. Acta Med Scand. 1963;173:115-119.
7. McIntyre H. Management, during dental surgery, of patients on anticoagulants. Lancet. 1966;2:99-100.
8. Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med. 1998;158:1610-1616.
9. Kallio H, Paloheimo M, Maunuksela EL. Haemorrhage and risk factors associated with retrobulbar/peribulbar block: a prospective study in 1383 patients. Br J Anaesth. 2000;85:708-711.
10. Gainey SP, Robertson DM, Fay W, Ilstrup D. Ocular surgery on patients receiving long-term warfarin therapy. Am J Ophthalmol. 1989;108:142-146.
11. Narendran N, Williamson TH. The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand. 2003;81:38-40.
12. Tuli SS, WuDunn D, Ciulla TA, Cantor LB. Delayed suprachoroidal hemorrhage after glaucoma filtration procedures. Ophthalmology. 2001;108:1808-1811.
13. Arnold PN. Study of acute intraoperative suprachoroidal hemorrhage. J Cataract Refract Surg. 1992;18:489-494.
14. Rotenstreich Y, Rubowitz A, Segev F, Jaeger-Roshu S, Assia EI. Effect of warfarin therapy on bleeding during cataract surgery. J Cataract Refract Surg. 2001;27:1344-1356.
15. McCormack P, Simock PR, Tullo AB. Management of the anticoagulated patient for ophthalmic surgery. Eye. 1993;7:749-750.
16. Morris A, Elder MJ. Warfarin therapy and cataract surgery. Clin Experiment Ophthalmol. 2000;28:419-422.
17. Carter K, Miller KM. Phacoemulsification and lens implantation in patients treated with aspirin or warfarin. J Cataract Refract Surg. 1998;24:1361-1364.
18. Katz J, Feldman MA, Bass EB, et al; Study of Medical Testing for Cataract Surgery Team. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery [erratum appears in Ophthalmology. 2003;110:2309]. Ophthalmology. 2003;110:1784-1788.
19. Custer PL, Trinkhaus KM. Hemorrhagic complications of oculoplastic surgery. Ophthal Plast Reconstr Surg. 2002;18:409-415.
20. Hall DL, Steen WH Jr, Drummond JW, Byrd WA. Anticoagulants and cataract surgery. Ophthalmic Surg. 1988;19:221-222.
21. McMahan LB. Anticoagulants and cataract surgery. J Cataract Refract Surg. 1988;14:569-571.
22. Robinson GA, Nylander A. Warfarin and cataract extraction. Br J Ophthalmol. 1989;73:702-703.
23. Bartley GB. Oculoplastic surgery in patients receiving warfarin: suggestions for management. Ophthal Plast Reconstr Surg. 1996;12:229-230.
24. Saitoh AK, Saitoh A, Taniguchi H, Amemiya T. Anticoagulation therapy and ocular surgery. Ophthalmic Surg Lasers. 1998;29:909-915.
25. Jonas JB, Pakdaman B, Sauder G. Cataract surgery under systemic anticoagulant therapy with coumarin. Eur J Ophthalmol. 2006;16:30-32.
26. Flaxel CJ, Blach RK. Aspirin is a hazard for vitreoretinal surgery. Br J Ophthalmol. 1996;80:486.
27. McDonald HR. Systemic anticoagulation and the preop retinal patient. Paper presented at: Retina Subspecialty Day; November 14, 2003; Anaheim, Calif.
28. van Dijk KN, Plat AW, van Dijk AA, et al. Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype. Thromb Haemost. 2004;91:95-101.
29. Chow DR, de Bustros S. Control of perioperative bleeding in vitreoretinal surgery. In: Ryan SJ, ed. Retina. Vol 3. 4th ed. Philadelphia, Pa: Elsevier Mosby; 2006:2451-2461.